Security Snapshot

Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) Institutional Ownership

CUSIP: 03209R103

13F Institutional Holders and Ownership History from Q2 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

160

Shares (Excl. Options)

18.92MFull value: 18,917,992 · shares · 30 Sep 2026

Price

$25.81

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,479,758
Value change
+$39,695,477
Number of holders
160
Security identity Names, identifiers, and filing context for this profile. 1 source field
Underlying class
Common Stock
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
44,328,981
SEC-reported price per share
$25.57
Insider filing price
$25.57
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock is tracked under CUSIP 03209R103.
  • 160 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 210 to 160 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $571.78MFull value: $571,780,673 · USD · 30 Jun 2026
    to
    $488.45MFull value: $488,446,123 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 160 institutions filings for Q3 2026.

Open SEC evidence

Security key

03209R103

13F reference period

Q3 2026

13F holders

160

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
AMPH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Zhang Jack Y. 25% $301,456,363 12,524,153 Jack Y. Zhang 31 Dec 2024
BlackRock, Inc. 12% $142,136,789 5,333,463 BlackRock, Inc. 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.2% $46,517,059 2,305,107 Dimensional Fund Advisors LP 30 Jun 2026
As of 30 Sep 2026, 160 institutional investors reported holding
18.92MFull value: 18,917,992 · shares · 30 Sep 2026
shares of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH). This represents 43% of the company’s total
44.33MFull value: 44,328,981 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
31%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
DIMENSIONAL FUND ADVISORS LP 5.4% 2,382,991 0.01% $61,508,120
STATE STREET CORP 3.8% 1,674,060 0% $43,207,489
VANGUARD CAPITAL MANAGEMENT LLC 2.8% 1,239,347 0% $31,987,546
MARSHALL WACE, LLP 2.7% 1,216,253 0.03% $31,391,492
GEODE CAPITAL MANAGEMENT, LLC 2.2% 970,452 0% $25,052,130
FULLER & THALER ASSET MANAGEMENT, INC. 2.1% 922,964 0.07% $23,821,699
VANGUARD PORTFOLIO MANAGEMENT LLC 1.8% 803,869 0% $20,747,859
GOLDMAN SACHS GROUP INC 1.3% 595,111 0% $15,359,814
RENAISSANCE TECHNOLOGIES LLC 1.2% 531,000 0.02% $13,705,110
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.1% 478,985 0.26% $12,362,648
Bridge City Capital, LLC 0.87% 383,901 2.1% $9,908,485
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.76% 335,850 0.02% $8,668,288
TWO SIGMA INVESTMENTS, LP 0.67% 299,086 0.01% $7,719,410
ALGERT GLOBAL LLC 0.67% 297,126 0.09% $7,668,822
Empowered Funds, LLC 0.56% 250,350 0.03% $6,461,534
VANGUARD FIDUCIARY TRUST CO 0.47% 207,168 0% $5,347,006
BANK OF AMERICA CORP /DE/ 0.44% 197,185 0% $5,089,345
Invesco Ltd. 0.4% 175,838 0% $4,538,378
Universal- Beteiligungs- und Servicegesellschaft mbH 0.37% 163,610 0.01% $4,222,774
NORDEA INVESTMENT MANAGEMENT AB 0.26% 115,926 0% $3,059,287
Public Sector Pension Investment Board 0.24% 107,036 0.01% $2,843,411
Vanguard Global Advisers, LLC 0.19% 85,831 0% $2,215,298
Creative Planning 0.18% 81,863 0% $2,112,884
ASSETMARK, INC 0.18% 79,124 0% $2,042,190
Legal & General Group Plc 0.16% 71,909 0% $1,855,971

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Headline period
Q3 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 18,917,992 $488,446,123 +$39,695,477 $25.81 160
2026 Q2 28,334,038 $571,780,673 -$76,684,185 $20.18 210
2026 Q1 32,346,840 $634,049,603 -$32,823,433 $19.59 214
2025 Q4 33,562,174 $898,754,913 +$25,045,961 $26.78 234
2025 Q3 32,747,166 $872,750,705 +$1,263,197 $26.65 240
2025 Q2 32,731,709 $751,532,890 -$21,672,562 $22.96 243
2025 Q1 33,249,489 $963,158,808 -$63,190,016 $28.99 240
2024 Q4 35,163,514 $1,305,816,189 -$16,188,647 $37.13 261
2024 Q3 35,330,537 $1,713,563,419 +$41,888,246 $48.53 276
2024 Q2 34,395,410 $1,376,025,520 +$31,905,251 $40.00 268
2024 Q1 33,566,615 $1,473,434,135 -$321,352 $43.91 271
2023 Q4 33,295,380 $2,059,042,180 +$87,201,045 $61.85 273
2023 Q3 32,003,084 $1,472,015,140 +$20,443,300 $45.99 253
2023 Q2 31,353,069 $1,801,848,806 +$73,791,648 $57.47 241
2023 Q1 30,206,509 $1,132,914,126 +$45,004,448 $37.50 216
2022 Q4 29,163,019 $817,271,726 -$23,406,379 $28.02 208
2022 Q3 29,873,966 $840,021,516 -$35,843,317 $28.10 196
2022 Q2 30,557,166 $1,062,910,134 +$40,970,389 $34.79 217
2022 Q1 29,830,020 $1,070,980,758 +$25,890,372 $35.90 201
2021 Q4 29,169,816 $678,795,680 +$19,582,653 $23.29 165
2021 Q3 27,926,297 $530,762,683 +$12,225,786 $19.01 136
2021 Q2 27,261,956 $549,556,724 +$25,712,540 $20.16 142
2021 Q1 26,031,138 $476,843,577 +$545,086 $18.32 129
2020 Q4 25,994,308 $522,683,040 -$2,775,804 $20.11 126
2020 Q3 26,220,579 $491,828,114 -$4,779,592 $18.75 131
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .